Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents Journal:Signal Transduction and Targeted Therapy | 1-Dec-2022 | ||
1-Mar-2023 | |||
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity Journal:Frontiers in Immunology | 20-Sep-2022 |